279 related articles for article (PubMed ID: 33842308)
21. Regulatory Forum commentary: alternative mouse models for future cancer risk assessment.
Morton D; Sistare FD; Nambiar PR; Turner OC; Radi Z; Bower N
Toxicol Pathol; 2014 Jul; 42(5):799-806. PubMed ID: 23965809
[TBL] [Abstract][Full Text] [Related]
22. Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.
Stei MM; Loeffler KU; Holz FG; Herwig MC
Biomed Res Int; 2016; 2016():4521807. PubMed ID: 27366747
[TBL] [Abstract][Full Text] [Related]
23. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
24. The next generation personalized models to screen hidden layers of breast cancer tumorigenicity.
Afzali F; Akbari P; Naderi-Manesh H; Gardaneh M
Breast Cancer Res Treat; 2019 Jun; 175(2):277-286. PubMed ID: 30810866
[TBL] [Abstract][Full Text] [Related]
25. Animal models in oral cancer research.
Mognetti B; Di Carlo F; Berta GN
Oral Oncol; 2006 May; 42(5):448-60. PubMed ID: 16266822
[TBL] [Abstract][Full Text] [Related]
26. Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression.
Asperger H; Stamm N; Gierke B; Pawlak M; Hofmann U; Zanger UM; Marton A; Katona RL; Buhala A; Vizler C; Cieslik JP; Ruckhäberle E; Niederacher D; Fehm T; Neubauer H; Ludescher M
Breast Cancer Res; 2020 Jul; 22(1):75. PubMed ID: 32660617
[TBL] [Abstract][Full Text] [Related]
27. Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer.
Steenbrugge J; Vander Elst N; Demeyere K; De Wever O; Sanders NN; Van Den Broeck W; Dirix L; Van Laere S; Meyer E
Front Immunol; 2019; 10():2928. PubMed ID: 31921184
[TBL] [Abstract][Full Text] [Related]
28. Mouse models of breast cancer.
Sakamoto K; Schmidt JW; Wagner KU
Methods Mol Biol; 2015; 1267():47-71. PubMed ID: 25636464
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxicity models of Huntington's disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies.
Calabrese EJ; Bhatia TN; Calabrese V; Dhawan G; Giordano J; Hanekamp YN; Kapoor R; Kozumbo WJ; Leak RK
Pharmacol Res; 2019 Dec; 150():104371. PubMed ID: 31415915
[TBL] [Abstract][Full Text] [Related]
30. In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches.
Simond AM; Muller WJ
Adv Cancer Res; 2020; 147():189-228. PubMed ID: 32593401
[TBL] [Abstract][Full Text] [Related]
31. Extracellular proteolysis in transgenic mouse models of breast cancer.
Almholt K; Green KA; Juncker-Jensen A; Nielsen BS; Lund LR; Rømer J
J Mammary Gland Biol Neoplasia; 2007 Mar; 12(1):83-97. PubMed ID: 17286208
[TBL] [Abstract][Full Text] [Related]
32. Targeting invadopodia for blocking breast cancer metastasis.
Meirson T; Gil-Henn H
Drug Resist Updat; 2018 Jul; 39():1-17. PubMed ID: 30075834
[TBL] [Abstract][Full Text] [Related]
33. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
34. Carcinogenesis of the Oral Cavity: Environmental Causes and Potential Prevention by Black Raspberry.
El-Bayoumy K; Chen KM; Zhang SM; Sun YW; Amin S; Stoner G; Guttenplan JB
Chem Res Toxicol; 2017 Jan; 30(1):126-144. PubMed ID: 28092946
[TBL] [Abstract][Full Text] [Related]
35. Genetic Rodent Models of Huntington Disease.
Stricker-Shaver J; Novati A; Yu-Taeger L; Nguyen HP
Adv Exp Med Biol; 2018; 1049():29-57. PubMed ID: 29427097
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Ciliogenesis Promotes Hedgehog Signaling, Tumorigenesis, and Metastasis in Breast Cancer.
Hassounah NB; Nunez M; Fordyce C; Roe D; Nagle R; Bunch T; McDermott KM
Mol Cancer Res; 2017 Oct; 15(10):1421-1430. PubMed ID: 28611083
[TBL] [Abstract][Full Text] [Related]
37. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.
Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS
Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176
[TBL] [Abstract][Full Text] [Related]
38. In vivo transgenic bioassays and assessment of the carcinogenic potential of pharmaceuticals.
Contrera JF; DeGeorge JJ
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):71-80. PubMed ID: 9539006
[TBL] [Abstract][Full Text] [Related]
39. Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model.
Shimizu Y; Furuya H; Tamashiro PM; Iino K; Chan OTM; Goodison S; Pagano I; Hokutan K; Peres R; Loo LWM; Hernandez B; Naing A; Chong CDK; Rosser CJ; Kawamori T
Carcinogenesis; 2018 Jan; 39(1):47-55. PubMed ID: 28968647
[TBL] [Abstract][Full Text] [Related]
40. Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.
Huang Y; Cheng C; Zhang C; Zhang Y; Chen M; Strand DW; Jiang M
Asian J Urol; 2016 Apr; 3(2):64-74. PubMed ID: 29264167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
